CXCL3: A Protein with Potential as A Drug Target and Biomarker

Target Name: CXCL3

NCBI ID: G2921

CXCL3

CXCL3: A Protein with Potential as A Drug Target and Biomarker

CXCL3 (also known as GRO3) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and intestines. It is a member of the CXCR4 family, which is a group of proteins that are involved in cell-cell adhesion and signaling.

One of the things that makes CXCL3 an interesting drug target is its role in the regulation of cell survival. CXCL3 has been shown to promote the survival of various cell types, including cancer cells, neuroprotective cells, and immune cells. This suggests that it may have potential as a drug for a variety of diseases, including cancer and neurodegenerative disorders.

In addition to its potential as a drug target, CXCL3 is also a potential biomarker. The expression of CXCL3 has been shown to be elevated in a variety of diseases, including cancer, neurodegenerative disorders, and chronic obstructive pulmonary disease (COPD). This suggests that it may be a useful indicator of disease progression or response to treatment.

Despite the potential benefits of CXCL3 as a drug target and biomarker, much more research is needed to fully understand its role in the body and its potential uses. One of the challenges in studying CXCL3 is its complex structure, as it is a member of a family of proteins that are involved in cell-cell adhesion and signaling. This makes it difficult to study the effects of CXCL3 in isolation, and to determine exactly how it works at the molecular level.

In addition to its potential as a drug target and biomarker, CXCL3 is also of interest to researchers because of its role in the regulation of cell signaling pathways. CXCL3 has been shown to be involved in a variety of signaling pathways, including the TGF-β pathway, the Wnt pathway, and the Hedgehog pathway. These pathways are involved in a wide range of biological processes, including cell growth, differentiation, and survival. As such, CXCL3 may be a useful target for drugs that are designed to modulate these pathways.

Overall, CXCL3 is an intriguing protein that has the potential to be a drug target and biomarker. While more research is needed to fully understand its role in the body and its potential uses, its complex structure and involvement in multiple signaling pathways make it an attractive candidate for further study.

Protein Name: C-X-C Motif Chemokine Ligand 3

Functions: Ligand for CXCR2 (By similarity). Has chemotactic activity for neutrophils. May play a role in inflammation and exert its effects on endothelial cells in an autocrine fashion. In vitro, the processed form GRO-gamma(5-73) shows a fivefold higher chemotactic activity for neutrophilic granulocytes

The "CXCL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CXCL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets